Anand Sneha, Pandey Prashant, Begum Mohammed Yasmin, Chidambaram Kumarappan, Arya Dilip Kumar, Gupta Ravi Kr, Sankhwar Ruchi, Jaiswal Shweta, Thakur Sunita, Rajinikanth Paruvathanahalli Siddalingam
Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow 226025, India.
Department of Pharmaceutics, King Khalid University, Abha 62529, Saudi Arabia.
Pharmaceuticals (Basel). 2022 Feb 28;15(3):302. doi: 10.3390/ph15030302.
Diabetic foot ulceration is the most distressing complication of diabetes having no standard therapy. Nanofibers are an emerging and versatile nanotechnology-based drug-delivery system with unique wound-healing properties. This study aimed to prepare and evaluate silk-sericin based hybrid nanofibrous mats for diabetic foot ulcer. The nanofibrous mats were prepared by electrospinning using silk sericin mixed with different proportions of polycaprolactone (PCL) and cellulose acetate (CA) loaded with ferulic acid (FA). The in vitro characterizations, such as surface morphology, mechanical properties, swelling behavior, biodegradability, scanning electron microscopy, and drug release were carried out. The SEM images indicated that nanofibers formed with varied diameters, ranging from 100 to 250 nm, and their tensile strength was found to range from 7 to 15 MPa. In vitro release demonstrated that the nanofibers sustained FA release over an extended time of period. In vitro cytotoxicity showed that the nanofibers possessed a lower cytotoxicity in HaCaT cells. The in vivo wound-healing studies demonstrated an excellent wound-healing efficiency of the nanofibers in diabetic rats. Furthermore, the histopathological studies showed the nanofibers' ability to restore the skin's normal structure. Therefore, it was concluded that the prepared silk-sericin-based hybrid nanofibers loaded with FA could be a promising drug-delivery platform for the effective treatment of diabetic foot ulcers.
糖尿病足溃疡是糖尿病最令人痛苦的并发症,且尚无标准治疗方法。纳米纤维是一种新兴的、基于纳米技术的多功能药物递送系统,具有独特的伤口愈合特性。本研究旨在制备并评估用于糖尿病足溃疡的丝胶蛋白基混合纳米纤维垫。通过静电纺丝制备纳米纤维垫,使用丝胶蛋白与不同比例的聚己内酯(PCL)和负载阿魏酸(FA)的醋酸纤维素(CA)混合。进行了体外表征,如表面形态、力学性能、溶胀行为、生物降解性、扫描电子显微镜和药物释放。扫描电子显微镜图像表明,形成的纳米纤维直径各异,范围为100至250纳米,其拉伸强度范围为7至15兆帕。体外释放表明,纳米纤维在较长时间内持续释放阿魏酸。体外细胞毒性表明,纳米纤维在HaCaT细胞中具有较低的细胞毒性。体内伤口愈合研究表明,纳米纤维在糖尿病大鼠中具有优异的伤口愈合效率。此外,组织病理学研究显示纳米纤维具有恢复皮肤正常结构的能力。因此,得出结论,所制备的负载阿魏酸的丝胶蛋白基混合纳米纤维可能是有效治疗糖尿病足溃疡的有前景的药物递送平台。